Median Technologies Reports Excellent Results from Its Indep

17.01.2024 - Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) today announces that it has achieved very positive results from the independent verification study for its CADe/CADx1 SaMD eyonis2 LCS (Lung Cancer Screening). This ... Seite 1

Related Keywords

United States , , Implications For Global Health , Innovations Leading , Youden Index , Median Technologies ,